Life Technologies Corporation today announced the launch of its Applied Biosystems QuantStudio™ Dx Real-Time PCR Instrument designed to meet the specific needs of clinical diagnostic laboratories. The ...

Recently, Life Technologies Corporation (LIFE) announced the launch of its Applied Biosystems QuantStudio Dx Real-Time PCR Instrument. The QuantStudio Dx is an in-vitro diagnostic (IVD) medical device ...

CARLSBAD, Calif.--(BUSINESS WIRE)--Thermo Fisher Scientific has certified the Applied Biosystems QuantStudio 7 Pro Dx Real-Time PCR System* to meet new In Vitro Medical Devices Regulation (IVDR) ...

CARLSBAD, CA and SAN DIEGO, CA--(Marketwired - Sep 16, 2013) - Quidel Corporation (NASDAQ: QDEL) and Life Technologies Corporation (NASDAQ: LIFE) announced today that the United States Food and Drug ...

DUBLIN--(BUSINESS WIRE)--The "Global qPCR Instruments Market Size, Share & Trends Analysis Report by Test Type (7500, QuantStudio Dx, QuantStudio 5, ViiA 7 Dx, One Step/One Step Plus, LightCycler 2.0, ...

The global qPCR instruments market size is expected to reach USD 1.64 billion by 2030. It is expected to expand at a CAGR of 7.0% from 2023 to 2030. The market is driven by the introduction of novel ...

Flagship qPCR instrument offers reliability, accuracy, ease of use and flexibility for IVD and lab-developed diagnostic tests Life Technologies Corporation (NASDAQ:LIFE) today announced the launch of ...

Flagship qPCR instrument offers reliability, accuracy, ease of use and flexibility for IVD and lab-developed diagnostic tests "Molecular diagnostic tests based on real-time PCR have become ...